1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc XNAS: SPRY

ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary co...

Read More
9.28 -0.06 (-0.64%)
50.90% Fall from 52W High
660.8K
XNAS Volume

XNAS 27 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for ARS Pharma Inc is on 11 Mar 2026 for the purpose of Leerink Conference See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Expensive Valuation
15.7 / 100
Momentum Score
Technically Neutral
37.1 / 100
Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM
Analyst Price Target
29
1Yr Price target upside is 211%
6 analysts

9

S

10

W

7

O

0

T

SWOT Analysis

ARS Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..